CN101554451A - Ginseng and antler muscle strengthening pills and preparation method thereof - Google Patents
Ginseng and antler muscle strengthening pills and preparation method thereof Download PDFInfo
- Publication number
- CN101554451A CN101554451A CNA2009100669503A CN200910066950A CN101554451A CN 101554451 A CN101554451 A CN 101554451A CN A2009100669503 A CNA2009100669503 A CN A2009100669503A CN 200910066950 A CN200910066950 A CN 200910066950A CN 101554451 A CN101554451 A CN 101554451A
- Authority
- CN
- China
- Prior art keywords
- radix
- rhizoma
- fructus
- pharmaceutical composition
- pills
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
Abstract
The invention relates to ginseng and antler muscle strengthening pills and a preparation method thereof, belonging to the field of natural Chinese herbal medicine. The type of drugs can regulate immune function, improve acetylcholine receptor function and strengthen muscle contraction ability. The drug formula is used for moistening lung, regulating qi, promoting production of fluid, strengthening spleen, strengthening kidney, replenishing essence, nourishing blood, soothing liver, strengthening muscle and increasing strength. The pills can effectively inhibit abnormal autoimmunity response and solve the acetylcholine transfer disorder. The pills have significant efficacy for myasthenia gravis.
Description
Technical field:
The present invention relates to a kind of Chinese patent medicine and preparation method thereof.Be specifically related to Chinese patent medicine of novel therapeutic myasthenia gravis and preparation method thereof.
Background technology:
Myasthenia gravis is to be generally acknowledged the world-famous puzzle that is difficult to cure by medical circle at present.Existing treatment way has only oral bromine to earn a bare living than this bright, intramuscular injection neostigmine and hormone medicine.Till the end of the year 2008, there are nearly 4,500,000 people to suffer from this type of disease both at home and abroad according to online record, seek less than the healing way.Because bromine is bigger than this bright dose individual variation, it is excessive and not enough that the patient takes the back dose, all can cause outbreak repeatedly, causes very big misery and financial burden to the patient.Still there is not at present the specific medicament of curing myasthenia gravis.
Summary of the invention:
The present invention discloses the inventor first through practical exploration for many years, inquires into the definite prescription of the treatment by Chinese herbs myasthenia gravis that sums up.Having overcome forefathers uses Chinese medicine decoction to treat the limitation of myasthenia gravis.On the basis of human body immunity improving function and activation acetylcholinergic receptor, strengthen the two-ways regulation ability of acetylcholine, fundamentally having solved the acetylcholine conductive obstruction, made muscle reach the normal contraction function, is to concentrate the marrow of medicine pharmacology to reach the purpose of curing myasthenia gravis.This product is without any side effects, is applicable to each age group, and first patient's effective percentage is reached 100%, and the patient with severe symptoms's effective percentage that shows effect is repeatedly reached 98%, and cure rate reaches more than 70%.
Therapeutic domain of the present invention also is applicable to: progressive muscular dystrophy, polymyositis, motor neuron.
The objective of the invention is to realize by following technical case.
1, its feature weight portion of ginseng antler muscle strengthening pills is:
Radix Puerariae 10-40 Rhizoma Gastrodiae 5-20 Radix Astragali 15-40 Poria 20-40 Radix Paeoniae Alba 10-40
Rhizoma Cyperi 10-40 Cortex Eucommiae 10-30 Rhizoma Cibotii 20-40 Radix Angelicae Sinensis 15-35 Radix Achyranthis Bidentatae 10-30
Fructus Lycii 20-50 Fructus Mori 20-50 Rhizoma Atractylodis Macrocephalae 10-40 Carapax et Plastrum Testudinis 5-20 Radix Panacis Quinquefolii 30-40
Fructus Tribuli 15-30 Radix Rehmanniae 10-40 Ramulus Cinnamomi 10-40 Radix Asparagi 20-40 Herba Epimedii 20-30
Radix Codonopsis 10-40 Fructus Jujubae 10-45 Radix Paeoniae Rubra 5-30 Radix Bupleuri 8-15 Radix Scutellariae 10-20
Radix Sophorae Flavescentis 10-15 Rhizoma Dioscoreae 10-20 Fructus Ligustri Lucidi 10-20 Herba Cistanches 15-25
2, its preferable feature weight portion of ginseng antler muscle strengthening pills is:
Radix Puerariae 25 Rhizoma Gastrodiaes 12 Radixs Astragali 30 Poria 30 Radix Paeoniae Albas 25
Rhizoma Cyperi 25 Cortexs Eucommiae 20 Rhizoma Cibotii 30 Radix Angelicae Sinensis 25 Radix Achyranthis Bidentataes 20
Fructus Lycii 35 Fructus Mori 35 Rhizoma Atractylodis Macrocephalaes 25 Carapax et Plastrum Testudiniss 15 Radix Panacis Quinquefoliis 35
Fructus Tribuli 20 Radix Rehmanniae 30 Ramulus Cinnamomi 20 Radix Asparagis 30 Herba Epimedii 25
Radix Codonopsis 25 Fructus Jujubaes 30 Radix Paeoniae Rubra 18 Radix Bupleuri 12 Radix Scutellariaes 15
Radix Sophorae Flavescentis 13 Rhizoma Dioscoreaes 15 Fructus Ligustri Lucidi 15 Herba Cistanches 20
Above Pharmaceutical composition can be made various forms of medicaments such as the watered pill, honeyed pill, oral liquid, granule, bagged steeping drug, tablet, capsule, concentrated pill by adopting various novel preparation methods, new technology, new techniques such as high efficiency extraction, separation.
Medicine of the present invention has lung moistening regulate the flow of vital energy, the promote the production of body fluid curative effect of spleen invigorating, the replenishing essence of reinforcing the kidney, soothing the liver, the dredge the meridian passage of nourishing blood, the strong power of strong flesh.After the patient takes medicine, the medicine focus of going directly, slight patient 7-10 days visible curative effects can be cured in 3 months; Fa Zuo patient with severe symptoms 1-3 month visible curative effect can be fully recovered in 6-12 month repeatedly.Effective percentage reaches 98%, and cure rate reaches more than 70%.
The specific embodiment:
Specify content of the present invention below by embodiment.In the present invention, the example of the following stated is in order better to set forth the present invention, is not to be used for limiting the scope of the invention.Pharmaceutical composition of the present invention can be made the watered pill, honeyed pill, oral liquid, granule, bagged steeping drug, tablet, capsule, powder, concentrated pill etc.Only illustrate below with the watered pill:
1, at first take by weighing following component:
Radix Puerariae 25 Rhizoma Gastrodiaes 12 Radixs Astragali 30 Poria 30 Radix Paeoniae Albas 25
Rhizoma Cyperi 25 Cortexs Eucommiae 20 Rhizoma Cibotii 30 Radix Angelicae Sinensis 25 Radix Achyranthis Bidentataes 20
Fructus Lycii 35 Fructus Mori 35 Rhizoma Atractylodis Macrocephalaes 25 Carapax et Plastrum Testudiniss 15 Radix Panacis Quinquefoliis 35
Fructus Tribuli 20 Radix Rehmanniae 30 Ramulus Cinnamomi 20 Radix Asparagis 30 Herba Epimedii 25
Radix Codonopsis 25 Fructus Jujubaes 30 Radix Paeoniae Rubra 18 Radix Bupleuri 12 Radix Scutellariaes 15
Radix Sophorae Flavescentis 13 Rhizoma Dioscoreaes 15 Fructus Ligustri Lucidi 15 Herba Cistanches 20
2, Radix Panacis Quinquefolii, Poria, Rhizoma Dioscoreae, Fructus Ligustri Lucidi, Fructus Mori etc. are cleaned respectively, remove impurity, dry after pulverizer is pulverized, grinder is ground into powder, crosses 100 mesh sieves, mix homogeneously; Herba Cistanches, the Radix Astragali, Carapax et Plastrum Testudinis, the Cortex Eucommiae, Rhizoma Cibotii, Radix Angelicae Sinensis, Radix Achyranthis Bidentatae, Fructus Lycii, the Rhizoma Atractylodis Macrocephalae, Radix Paeoniae Rubra, Rhizoma Gastrodiae, Fructus Tribuli etc. carry out the high temperature extraction, are condensed into cream, dry and grind into powder to 100 orders.Above two kinds of powder mixes are even, make the watered pill traditionally.
Medicine of the present invention is that the clinical experience that the inventor summed up 15 years develops.The over one hundred example of treatment myasthenia gravis patient, effective percentage 98%, cure rate is more than 70%.
Now illustrate:
1, patient Liu Longyi, man, 59 years old, people from Changchun, Jilin Province suffered from myasthenia gravis 3 years, the thymic hyperplasia postoperative, take bright excessive the occur crisis of bromine than this, execute tracheotomy once more and earn a bare living with respirator, the postoperative doctor trained in Western medicine adopts various high-quality drug treatments to there is no curative effect, postoperative inventor's first visit in 8 days, this square preparation of nasal feeding, crisis is alleviated after 6 days, separating respiratory machine recovers autonomous respiration after 7 days, take care of oneself after 3 months, recovery from illness in 6 months is followed up a case by regular visits to and was not seen recurrence in 1 year.
2, patient Li Yingqiang, the man, 25 years old, people from Changchun, Jilin Province just suffered from myasthenia gravis, and eyelid is independently not sagging, myasthenia of limbs, dysphagia, relies on bromine bright than this, keeps orthobiosis.Come institute's hospitalization on 19th in JIUYUE in 2008, take and end this patient this square preparation on January 19th, 2009 and withdraw bromine bright than this, can work orthobiosis, do not see recurrence so far.
Claims (9)
1, the ginseng antler muscle strengthening pills is characterized in that comprising the compositions of following Chinese medicine:
The Radix Puerariae Rhizoma Gastrodiae Radix Astragali Poria Radix Paeoniae Alba
Rhizoma Cyperi Cortex Eucommiae Rhizoma Cibotii Radix Angelicae Sinensis Radix Achyranthis Bidentatae
Fructus Lycii Fructus Mori Rhizoma Atractylodis Macrocephalae Carapax et Plastrum Testudinis Radix Panacis Quinquefolii
Fructus Tribuli Radix Rehmanniae Ramulus Cinnamomi Radix Asparagi Herba Epimedii
Radix Codonopsis Fructus Jujubae Radix Paeoniae Rubra Radix Bupleuri Radix Scutellariae
Radix Sophorae Flavescentis Rhizoma Dioscoreae Fructus Ligustri Lucidi Herba Cistanches
2, the Pharmaceutical composition in the claim 1 is characterized in that according to different situations, and the medicine of prescription constitutes kind can carry out the part increase and decrease, forms different refinement prescriptions.
3, the pharmaceutical composition in the claim 1 is characterized in that its component weight portion is
Radix Puerariae 10-40 Rhizoma Gastrodiae 5-20 Radix Astragali 15-40 Poria 20-40 Radix Paeoniae Alba 10-40
Rhizoma Cyperi 10-40 Cortex Eucommiae 10-30 Rhizoma Cibotii 20-40 Radix Angelicae Sinensis 15-35 Radix Achyranthis Bidentatae 10-30
Fructus Lycii 20-50 Fructus Mori 20-50 Rhizoma Atractylodis Macrocephalae 10-40 Carapax et Plastrum Testudinis 5-20 Radix Panacis Quinquefolii 30-40
Fructus Tribuli 15-30 Radix Rehmanniae 10-40 Ramulus Cinnamomi 10-40 Radix Asparagi 20-40 Herba Epimedii 20-30
Radix Codonopsis 10-40 Fructus Jujubae 10-45 Radix Paeoniae Rubra 5-30 Radix Bupleuri 8-15 Radix Scutellariae 10-20
Radix Sophorae Flavescentis 10-15 Rhizoma Dioscoreae 10-20 Fructus Ligustri Lucidi 10-20 Herba Cistanches 15-25
4, the pharmaceutical composition in the claim 1 is characterized in that the preferable weight portion of its component is
Radix Puerariae 25 Rhizoma Gastrodiaes 12 Radixs Astragali 30 Poria 30 Radix Paeoniae Albas 25
Rhizoma Cyperi 25 Cortexs Eucommiae 20 Rhizoma Cibotii 30 Radix Angelicae Sinensis 25 Radix Achyranthis Bidentataes 20
Fructus Lycii 35 Fructus Mori 35 Rhizoma Atractylodis Macrocephalaes 25 Carapax et Plastrum Testudiniss 15 Radix Panacis Quinquefoliis 35
Fructus Tribuli 20 Radix Rehmanniae 30 Ramulus Cinnamomi 20 Radix Asparagis 30 Herba Epimedii 25
Radix Codonopsis 25 Fructus Jujubaes 30 Radix Paeoniae Rubra 18 Radix Bupleuri 12 Radix Scutellariaes 15
Radix Sophorae Flavescentis 13 Rhizoma Dioscoreaes 15 Fructus Ligustri Lucidi 15 Herba Cistanches 20
5, the Pharmaceutical composition in the claim 1,3,4 in claim 2, is characterized in that according to different situations, and the amount of different Chinese medicinal ingredients also can increase and decrease in the prescription.
6, the preparation of drug combination method in the claim 1, it is characterized in that: Radix Panacis Quinquefolii, Poria, Rhizoma Dioscoreae, Fructus Ligustri Lucidi, Fructus Mori etc. clean respectively, remove impurity, dry after pulverizer is pulverized, and grinder is ground into powder, crosses 100 mesh sieves, mix homogeneously; Herba Cistanches, the Radix Astragali, Carapax et Plastrum Testudinis, the Cortex Eucommiae, Rhizoma Cibotii, Radix Angelicae Sinensis, Radix Achyranthis Bidentatae, Fructus Lycii, the Rhizoma Atractylodis Macrocephalae, Radix Paeoniae Rubra, Rhizoma Gastrodiae, Fructus Tribuli etc. carry out the high temperature extraction, are condensed into cream, dry and grind into powder to 100 orders.Above two kinds of powder mixes are made the watered pill evenly, traditionally.
7, according to the described Pharmaceutical composition of claim 1, it is characterized in that not only can making watered pill, also can write out a prescription according to the present invention, adopt different preparation methoies, Pharmaceutical composition of the present invention is made honey pill agent, oral liquid, granule, bagged steeping drug, tablet, capsule, powder, concentrated pill etc.
8,, it is characterized in that it being a kind of medicine that is used for the treatment of myasthenia gravis, progressive muscular dystrophy, polymyositis, a series of diseases that motor neuron caused according to the described Pharmaceutical composition of claim 1.
9,, it is characterized in that its title is not limited to " ginseng antler muscle strengthening pills " according to being a kind of Pharmaceutical composition described in the claim 1.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNA2009100669503A CN101554451A (en) | 2009-05-14 | 2009-05-14 | Ginseng and antler muscle strengthening pills and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNA2009100669503A CN101554451A (en) | 2009-05-14 | 2009-05-14 | Ginseng and antler muscle strengthening pills and preparation method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN101554451A true CN101554451A (en) | 2009-10-14 |
Family
ID=41172833
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNA2009100669503A Pending CN101554451A (en) | 2009-05-14 | 2009-05-14 | Ginseng and antler muscle strengthening pills and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101554451A (en) |
Cited By (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102793882A (en) * | 2012-08-25 | 2012-11-28 | 梁立祥 | Traditional Chinese medicine for treatment of myasthenia gravis |
| CN103083561A (en) * | 2013-03-05 | 2013-05-08 | 柯任可 | Medicinal composition with nourishing and body building effects |
| CN104147277A (en) * | 2014-08-29 | 2014-11-19 | 郑树旺 | Traditional Chinese medicinal preparation for treating myasthenia gravis and preparation method |
| CN104547492A (en) * | 2015-01-01 | 2015-04-29 | 信阳农林学院 | Traditional Chinese medicine liquor for preventing and treating postpartum low fever of female animals and preparation method of traditional Chinese medicine liquor |
| CN104721536A (en) * | 2015-04-15 | 2015-06-24 | 刘卓韬 | TCM (traditional Chinese medicine) composition for treating progressive muscular dystrophy and uses thereof in acupoint combined acupuncture |
| CN105250887A (en) * | 2015-11-27 | 2016-01-20 | 刘艳丽 | Traditional Chinese medicine electuary for treatment and nursing of ICU myasthenia gravis and preparation method |
| WO2017121333A1 (en) * | 2016-01-12 | 2017-07-20 | 杏辉天力（杭州）药业有限公司 | Use of cistanche tubulosa extract and isoacteoside in protection of muscles |
| CN108785586A (en) * | 2018-07-06 | 2018-11-13 | 岳茂兴 | A kind of Chinese medicine composition and application for auxiliary treatment motor neuron disease |
-
2009
- 2009-05-14 CN CNA2009100669503A patent/CN101554451A/en active Pending
Cited By (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102793882A (en) * | 2012-08-25 | 2012-11-28 | 梁立祥 | Traditional Chinese medicine for treatment of myasthenia gravis |
| CN103083561A (en) * | 2013-03-05 | 2013-05-08 | 柯任可 | Medicinal composition with nourishing and body building effects |
| CN104147277A (en) * | 2014-08-29 | 2014-11-19 | 郑树旺 | Traditional Chinese medicinal preparation for treating myasthenia gravis and preparation method |
| CN104547492A (en) * | 2015-01-01 | 2015-04-29 | 信阳农林学院 | Traditional Chinese medicine liquor for preventing and treating postpartum low fever of female animals and preparation method of traditional Chinese medicine liquor |
| CN104721536A (en) * | 2015-04-15 | 2015-06-24 | 刘卓韬 | TCM (traditional Chinese medicine) composition for treating progressive muscular dystrophy and uses thereof in acupoint combined acupuncture |
| CN105250887A (en) * | 2015-11-27 | 2016-01-20 | 刘艳丽 | Traditional Chinese medicine electuary for treatment and nursing of ICU myasthenia gravis and preparation method |
| WO2017121333A1 (en) * | 2016-01-12 | 2017-07-20 | 杏辉天力（杭州）药业有限公司 | Use of cistanche tubulosa extract and isoacteoside in protection of muscles |
| US9931367B2 (en) | 2016-01-12 | 2018-04-03 | Sinphar Tian-Li Pharmaceutical Co., Ltd. (Hangzhou) | Uses of cistanche tubulosa extract and isoacteoside in protecting muscle |
| CN108785586A (en) * | 2018-07-06 | 2018-11-13 | 岳茂兴 | A kind of Chinese medicine composition and application for auxiliary treatment motor neuron disease |
| CN108785586B (en) * | 2018-07-06 | 2021-06-08 | 岳茂兴 | Traditional Chinese medicine composition for adjuvant therapy of motor neuron diseases and application |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102266520B (en) | Traditional Chinese medicine composition for treating diabetes | |
| CN101554451A (en) | Ginseng and antler muscle strengthening pills and preparation method thereof | |
| CN103566350A (en) | Pharmaceutical composition having blood sugar reducing effect | |
| CN101972443B (en) | Chinese medicinal formula for treating chronic gastritis | |
| CN103705866A (en) | Traditional Chinese medicine composition for treating hypomenorrhea | |
| CN101129496A (en) | Traditional Chinese medicine for treating obstinate headache | |
| CN102363022B (en) | Chinese medicine for treating postpartum anemic fainting | |
| CN101164611A (en) | Traditional Chinese medicine for treating invasion of lung by cold type pertussis | |
| CN101199796B (en) | External antidiarrhoeal medicament, preparing method and function thereof | |
| CN101366903B (en) | Traditional Chinese medicine composition for treating climacteric syndrome | |
| CN101167932A (en) | Traditional Chinese medicine for treating chronic hepatitis B | |
| CN102657736B (en) | Medicament composition for treating rheumatoid arthritis and preparation method of medicament composition | |
| CN102488846B (en) | Medicinal composition for treating diabetes mellitus | |
| CN101130053A (en) | Traditional Chinese medicine for treating exogenous injury type blood stasis headache | |
| CN103041234A (en) | Atrophy inhibiting and stomach nourishing capsule | |
| CN101129695A (en) | Traditional Chinese medicine for treating liver depression headache | |
| CN103721082A (en) | Traditional Chinese medicinal composition for treating scapulohumeral periarthritis | |
| CN101129893A (en) | Traditional Chinese medicine for treating cervical vertebra disease combined with diarrhea | |
| CN103800689A (en) | Traditional Chinese medicine composition for treating diabetes mellitus | |
| CN101143205A (en) | Traditional Chinese medicine for treating qi deficiency fever | |
| CN101843829B (en) | Chinese medicament for treating pulmonary heart diseases | |
| CN101130003A (en) | Traditional Chinese medicine for treating acute cholecystitis | |
| CN101143182A (en) | Traditional Chinese medicine for treating alcoholic cirrhosis | |
| CN103566349A (en) | Medicinal composition for treating hyperglycemia and hyperlipidemia | |
| CN101129694A (en) | Traditional Chinese medicine for treating muscular contraction headache |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20091014 |